, Volume 22, Issue 1, pp 6-12
Date: 05 Jan 2007

Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s Seniors

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Context

Understanding and improving the quality of medication management is particularly important in the context of the Medicare prescription drug benefit that took effect last January 2006.

Objective

To determine the prevalence of physician–patient dialogue about medication cost and medication adherence among elderly adults nationwide.

Design

Cross-sectional survey.

Participants

National stratified random sample of community-dwelling Medicare beneficiaries aged 65 and older.

Main Outcome Measures

Rates of physician–patient dialogue about nonadherence and cost-related medication switching.

Results

Forty-one percent of seniors reported taking five or more prescription medications, and more than half has 2 or more prescribing physicians. Thirty-two percent overall and 24% of those with 3 or more chronic conditions reported not having talked with their doctor about all their different medicines in the last 12 months. Of seniors reporting skipping doses or stopping a medication because of side effects or perceived nonefficacy, 27% had not talked with a physician about it. Of those reporting cost-related nonadherence, 39% had not talked with a physician about it. Thirty-eight percent of those with cost-related nonadherence reported switching to a lower priced drug, and in a multivariable model, having had a discussion about drug cost was significantly associated with this switch (odds ratio [OR] 5.04, 95% confidence interval [CI] 4.28–5.93, P < .001).

Conclusions

We show that there is a communication gap between seniors and their physicians around prescription medications. This communication problem is an important quality and safety issue, and takes on added salience as physicians and patients confront new challenges associated with coverage under new Medicare prescription drug plans. Meeting these challenges will require that more attention be devoted to medication management during all clinical encounters.